Inflexion is a unique and ambitious firm with a highly talented and entrepreneurial team which I’m excited to be a part of.
Saloshnee is an Assistant Director and is responsible for transaction execution as well as supporting the origination of majority and minority investment opportunities. She was involved in our investments in Rosemont Pharmceuticals, Pharmaspectra and Atcore.
Prior to joining Inflexion, Saloshnee spent six years at Gleacher Shacklock, where she gained corporate finance experience from working on a range of deals including the sale of the NEC Group, the acquisition of Phase Eight and the IPO of Nobina.
Outside of the office, Saloshnee enjoys following rugby and cricket, travelling and dining out. She has a BSc in Economics and Geography from University College London.